Abstract
Summary
7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone is a key intermediate in the synthesis of aripiprazole, a new atypical antischizophrenia drug that has an effect on DA. The nervous system has a two-way regulatory effect and is a stabilizer of DA transmitter.
The global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Industry Forecast” looks at past sales and reviews total world 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone sales in 2023, providing a comprehensive analysis by region and market sector of projected 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone sales for 2024 through 2030. With 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone industry.
This Insight Report provides a comprehensive analysis of the global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone.
United States market for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone players cover Suven Life Sciences, M/S Panamit International, ChemFocus, AQChem, OX CHEM, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity 99%
Purity 98%
Others
Segmentation by Application:
Pharmaceutical Intermediates
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Suven Life Sciences
M/S Panamit International
ChemFocus
AQChem
OX CHEM
Urantiis Pharmaceuticals
NB Healthcare
Chemicea Pharmaceuticals
Shreeneel Chemicals
Chemeca Drugs
Anugraha Chemicals
Neugen Labs
Jingyu Group
AnQing Chico
Nanjing CoreTech Biomedical
Hangzhou FST Pharmaceutical
Xuzhou Nuote Chemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market?
What factors are driving 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market opportunities vary by end market size?
How does 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone break out by Type, by Application?
The global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Industry Forecast” looks at past sales and reviews total world 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone sales in 2023, providing a comprehensive analysis by region and market sector of projected 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone sales for 2024 through 2030. With 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone industry.
This Insight Report provides a comprehensive analysis of the global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone.
United States market for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone players cover Suven Life Sciences, M/S Panamit International, ChemFocus, AQChem, OX CHEM, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity 99%
Purity 98%
Others
Segmentation by Application:
Pharmaceutical Intermediates
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Suven Life Sciences
M/S Panamit International
ChemFocus
AQChem
OX CHEM
Urantiis Pharmaceuticals
NB Healthcare
Chemicea Pharmaceuticals
Shreeneel Chemicals
Chemeca Drugs
Anugraha Chemicals
Neugen Labs
Jingyu Group
AnQing Chico
Nanjing CoreTech Biomedical
Hangzhou FST Pharmaceutical
Xuzhou Nuote Chemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market?
What factors are driving 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone market opportunities vary by end market size?
How does 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone break out by Type, by Application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone by Country/Region, 2019, 2023 & 2030
2.2 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Segment by Type
2.2.1 Purity 99%
2.2.2 Purity 98%
2.2.3 Others
2.3 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Type
2.3.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales Market Share by Type (2019-2024)
2.3.2 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Revenue and Market Share by Type (2019-2024)
2.3.3 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sale Price by Type (2019-2024)
2.4 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Segment by Application
2.4.1 Pharmaceutical Intermediates
2.4.2 Others
2.5 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Application
2.5.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sale Market Share by Application (2019-2024)
2.5.2 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Revenue and Market Share by Application (2019-2024)
2.5.3 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Breakdown Data by Company
3.1.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Annual Sales by Company (2019-2024)
3.1.2 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales Market Share by Company (2019-2024)
3.2 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Annual Revenue by Company (2019-2024)
3.2.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Revenue by Company (2019-2024)
3.2.2 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Revenue Market Share by Company (2019-2024)
3.3 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sale Price by Company
3.4 Key Manufacturers 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Location Distribution
3.4.2 Players 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone by Geographic Region
4.1 World Historic 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Market Size by Geographic Region (2019-2024)
4.1.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Annual Sales by Geographic Region (2019-2024)
4.1.2 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Market Size by Country/Region (2019-2024)
4.2.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Annual Sales by Country/Region (2019-2024)
4.2.2 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Annual Revenue by Country/Region (2019-2024)
4.3 Americas 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales Growth
4.4 APAC 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales Growth
4.5 Europe 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales Growth
4.6 Middle East & Africa 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales Growth
5 Americas
5.1 Americas 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Country
5.1.1 Americas 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Country (2019-2024)
5.1.2 Americas 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Revenue by Country (2019-2024)
5.2 Americas 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Type (2019-2024)
5.3 Americas 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Region
6.1.1 APAC 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Region (2019-2024)
6.1.2 APAC 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Revenue by Region (2019-2024)
6.2 APAC 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Type (2019-2024)
6.3 APAC 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone by Country
7.1.1 Europe 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Country (2019-2024)
7.1.2 Europe 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Revenue by Country (2019-2024)
7.2 Europe 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Type (2019-2024)
7.3 Europe 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone by Country
8.1.1 Middle East & Africa 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Country (2019-2024)
8.1.2 Middle East & Africa 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Revenue by Country (2019-2024)
8.2 Middle East & Africa 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Type (2019-2024)
8.3 Middle East & Africa 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone
10.3 Manufacturing Process Analysis of 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone
10.4 Industry Chain Structure of 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Distributors
11.3 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Customer
12 World Forecast Review for 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone by Geographic Region
12.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Market Size Forecast by Region
12.1.1 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Forecast by Region (2025-2030)
12.1.2 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Forecast by Type (2025-2030)
12.7 Global 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Suven Life Sciences
13.1.1 Suven Life Sciences Company Information
13.1.2 Suven Life Sciences 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.1.3 Suven Life Sciences 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Suven Life Sciences Main Business Overview
13.1.5 Suven Life Sciences Latest Developments
13.2 M/S Panamit International
13.2.1 M/S Panamit International Company Information
13.2.2 M/S Panamit International 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.2.3 M/S Panamit International 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 M/S Panamit International Main Business Overview
13.2.5 M/S Panamit International Latest Developments
13.3 ChemFocus
13.3.1 ChemFocus Company Information
13.3.2 ChemFocus 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.3.3 ChemFocus 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ChemFocus Main Business Overview
13.3.5 ChemFocus Latest Developments
13.4 AQChem
13.4.1 AQChem Company Information
13.4.2 AQChem 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.4.3 AQChem 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AQChem Main Business Overview
13.4.5 AQChem Latest Developments
13.5 OX CHEM
13.5.1 OX CHEM Company Information
13.5.2 OX CHEM 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.5.3 OX CHEM 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 OX CHEM Main Business Overview
13.5.5 OX CHEM Latest Developments
13.6 Urantiis Pharmaceuticals
13.6.1 Urantiis Pharmaceuticals Company Information
13.6.2 Urantiis Pharmaceuticals 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.6.3 Urantiis Pharmaceuticals 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Urantiis Pharmaceuticals Main Business Overview
13.6.5 Urantiis Pharmaceuticals Latest Developments
13.7 NB Healthcare
13.7.1 NB Healthcare Company Information
13.7.2 NB Healthcare 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.7.3 NB Healthcare 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 NB Healthcare Main Business Overview
13.7.5 NB Healthcare Latest Developments
13.8 Chemicea Pharmaceuticals
13.8.1 Chemicea Pharmaceuticals Company Information
13.8.2 Chemicea Pharmaceuticals 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.8.3 Chemicea Pharmaceuticals 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Chemicea Pharmaceuticals Main Business Overview
13.8.5 Chemicea Pharmaceuticals Latest Developments
13.9 Shreeneel Chemicals
13.9.1 Shreeneel Chemicals Company Information
13.9.2 Shreeneel Chemicals 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.9.3 Shreeneel Chemicals 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shreeneel Chemicals Main Business Overview
13.9.5 Shreeneel Chemicals Latest Developments
13.10 Chemeca Drugs
13.10.1 Chemeca Drugs Company Information
13.10.2 Chemeca Drugs 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.10.3 Chemeca Drugs 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Chemeca Drugs Main Business Overview
13.10.5 Chemeca Drugs Latest Developments
13.11 Anugraha Chemicals
13.11.1 Anugraha Chemicals Company Information
13.11.2 Anugraha Chemicals 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.11.3 Anugraha Chemicals 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Anugraha Chemicals Main Business Overview
13.11.5 Anugraha Chemicals Latest Developments
13.12 Neugen Labs
13.12.1 Neugen Labs Company Information
13.12.2 Neugen Labs 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.12.3 Neugen Labs 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Neugen Labs Main Business Overview
13.12.5 Neugen Labs Latest Developments
13.13 Jingyu Group
13.13.1 Jingyu Group Company Information
13.13.2 Jingyu Group 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.13.3 Jingyu Group 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Jingyu Group Main Business Overview
13.13.5 Jingyu Group Latest Developments
13.14 AnQing Chico
13.14.1 AnQing Chico Company Information
13.14.2 AnQing Chico 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.14.3 AnQing Chico 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 AnQing Chico Main Business Overview
13.14.5 AnQing Chico Latest Developments
13.15 Nanjing CoreTech Biomedical
13.15.1 Nanjing CoreTech Biomedical Company Information
13.15.2 Nanjing CoreTech Biomedical 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.15.3 Nanjing CoreTech Biomedical 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Nanjing CoreTech Biomedical Main Business Overview
13.15.5 Nanjing CoreTech Biomedical Latest Developments
13.16 Hangzhou FST Pharmaceutical
13.16.1 Hangzhou FST Pharmaceutical Company Information
13.16.2 Hangzhou FST Pharmaceutical 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.16.3 Hangzhou FST Pharmaceutical 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Hangzhou FST Pharmaceutical Main Business Overview
13.16.5 Hangzhou FST Pharmaceutical Latest Developments
13.17 Xuzhou Nuote Chemical
13.17.1 Xuzhou Nuote Chemical Company Information
13.17.2 Xuzhou Nuote Chemical 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Product Portfolios and Specifications
13.17.3 Xuzhou Nuote Chemical 7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Xuzhou Nuote Chemical Main Business Overview
13.17.5 Xuzhou Nuote Chemical Latest Developments
14 Research Findings and Conclusion